Aardvark Therapeutics, Inc. announces an $85 million oversubscribed Series C financing led by Decheng Capital, with participation from Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon ...
A small San Diego biotech wants to take a different approach to the weight loss drug R&D field by going after hunger rather ...
National Interest on MSN15h
F-111 Aardvark: The Warplane Built to Strike Just About AnythingAardvark, a groundbreaking aircraft known for its innovative technologies, served the US Air Force from the 1960s to 1996 and ...
San Diego-based Aardvark Therapeutics announced today that it has raised $85M in a Series C funding round. The funding was led by Decheng Capital and also included Cormorant Asset Management, ...
The National Interest on MSN17h
Russia's MiG-23 Fighter Has Something the Air Force Can't Ever MatchThe MiG-23 "Flogger," designed during the Cold War to match the U.S. F-4 Phantom, ended up with a disappointing legacy due to ...
The total debt drawn at the end of Q1 2024 was $165.0 million compared to $125.0 million at December 31, 2023. The increase ...
The Company's annual general and special meeting of shareholders will be held at the office of Blake, Cassels & Graydon LLP, 1133 Melville Street, Suite 3500, Vancouver, BC V6E 4E5, Canada on May 10, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback